J&J | JNJ - Selling And Administration Expenses

Stock Price
227.50
Daily Change
-3.15 -1.37%
Monthly
-5.18%
Yearly
47.17%
Q2 Forecast
229.03

J&J reported $6.03B in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
AbbVie USD 3.89B 325M Dec/2025
Abbott USD 3.27B 138M Mar/2026
Amgen USD 1.94B 237M Dec/2025
AstraZeneca USD 4.61B 4.46B Dec/2025
Baxter International USD 761M 53M Dec/2025
Bayer EUR 4.05B 647M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Biogen USD 545.2M 38.6M Sep/2025
Boston Scientific USD 1.83B 93M Dec/2025
Bristol-Myers Squibb USD 2.18B 392M Dec/2025
CONMED USD 166.76M 26.42M Dec/2025
Cooper Companies USD 373.1M 46.1M Dec/2025
Dexcom USD 299.9M 31.5M Dec/2025
Edwards Lifesciences USD 522.2M 80.7M Mar/2026
Eli Lilly USD 3.13B 391.3M Dec/2025
Gilead Sciences USD 1.78B 425M Dec/2025
GlaxoSmithKline GBP 2.68B 518M Dec/2025
Globus Medical USD 318.48M 4.88M Dec/2025
Insulet USD 331.4M 16.2M Dec/2025
Integra LifeSciences USD 156.45M 12.6M Dec/2025
Intuitive Surgical USD 613.3M 73.8M Mar/2026
J&J USD 6.03B 719M Mar/2026
Medtronic 2.97B 159M Sep/2025
Merck USD 2.85B 215M Dec/2025
Merit Medical Systems USD 114.83M 7.45M Dec/2025
Novartis USD 3.44B 128M Dec/2025
Pfizer USD 4.08B 894M Dec/2025
Regeneron Pharmaceuticals USD 775M 117.2M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.33B 419M Mar/2026
Stryker USD 2.14B 150M Dec/2025
Tandem Diabetes Care USD 99.86M 5.34M Dec/2025
Teva Pharmaceutical Industries USD 1.12B 147M Dec/2025
Vertex Pharmaceuticals USD 487M 41.9M Dec/2025
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025
Zoetis USD 619M 40M Dec/2025